A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

NCT04543695 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

255

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

COMBINATION_PRODUCT: Concurrent Chemoradiotherapy
DRUG: XELOX
DRUG: mFOLFOX
PROCEDURE: TME

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]